These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10665340)

  • 21. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction.
    Byon JC; Kusari AB; Kusari J
    Mol Cell Biochem; 1998 May; 182(1-2):101-8. PubMed ID: 9609119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein tyrosine phosphatase 1B in hematopoiesis.
    Heinonen KM; Tremblay ML
    Cell Cycle; 2006 May; 5(10):1053-6. PubMed ID: 16687929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein-tyrosine phosphatase 1B as a potential drug target for obesity.
    Dadke S; Chernoff J
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):299-304. PubMed ID: 14683461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New clues found to diabetes and obesity.
    Ferber D
    Science; 1999 Mar; 283(5407):1423, 1425. PubMed ID: 10206863
    [No Abstract]   [Full Text] [Related]  

  • 25. Human protein tyrosine phosphatase 1B inhibitors: QSAR by genetic function approximation.
    Sachan N; Kadam SS; Kulkarni VM
    J Enzyme Inhib Med Chem; 2007 Jun; 22(3):267-76, 371-3. PubMed ID: 17674807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein tyrosine phosphatases: the quest for negative regulators of insulin action.
    Asante-Appiah E; Kennedy BP
    Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E663-70. PubMed ID: 12626322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Pro387Leu variant of protein tyrosine phosphatase-1B is not associated with diabetes mellitus type 2 in a German population.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    J Intern Med; 2005 Mar; 257(3):272-80. PubMed ID: 15715684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The development of potent non-peptidic PTP-1B inhibitors.
    Dufresne C; Roy P; Wang Z; Asante-Appiah E; Cromlish W; Boie Y; Forghani F; Desmarais S; Wang Q; Skorey K; Waddleton D; Ramachandran C; Kennedy BP; Xu L; Gordon R; Chan CC; Leblanc Y
    Bioorg Med Chem Lett; 2004 Feb; 14(4):1039-42. PubMed ID: 15013019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents - A brief review.
    Verma M; Gupta SJ; Chaudhary A; Garg VK
    Bioorg Chem; 2017 Feb; 70():267-283. PubMed ID: 28043717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance.
    Kusari J; Kenner KA; Suh KI; Hill DE; Henry RR
    J Clin Invest; 1994 Mar; 93(3):1156-62. PubMed ID: 8132755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice.
    Gum RJ; Gaede LL; Koterski SL; Heindel M; Clampit JE; Zinker BA; Trevillyan JM; Ulrich RG; Jirousek MR; Rondinone CM
    Diabetes; 2003 Jan; 52(1):21-8. PubMed ID: 12502489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
    Wang C; Wang L; Yang Z
    Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in Oji-Cree.
    Mok A; Cao H; Zinman B; Hanley AJ; Harris SB; Kennedy BP; Hegele RA
    J Clin Endocrinol Metab; 2002 Feb; 87(2):724-7. PubMed ID: 11836311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice.
    Kushner JA; Haj FG; Klaman LD; Dow MA; Kahn BB; Neel BG; White MF
    Diabetes; 2004 Jan; 53(1):61-6. PubMed ID: 14693698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes.
    Gonzalez-Rodriguez A; Clampit JE; Escribano O; Benito M; Rondinone CM; Valverde AM
    Endocrinology; 2007 Feb; 148(2):594-608. PubMed ID: 17068137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered regulation of SHP-2 and PTP 1B tyrosine phosphatases in cystic kidneys from bcl-2 -/- mice.
    Sorenson CM; Sheibani N
    Am J Physiol Renal Physiol; 2002 Mar; 282(3):F442-50. PubMed ID: 11832424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A diabetes switch?
    Gibbs WW
    Sci Am; 1999 Jun; 280(6):16. PubMed ID: 10349730
    [No Abstract]   [Full Text] [Related]  

  • 38. [Research progress of several protein tyrosine phosphatases in diabetes].
    Chen M; Sun JP; Liu J; Yu X
    Sheng Li Xue Bao; 2010 Apr; 62(2):179-89. PubMed ID: 20401454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances.
    Harley EA; Levens N
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1179-89. PubMed ID: 14649209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic characterization of the human and mouse protein tyrosine phosphatase-1B genes.
    Forsell PA; Boie Y; Montalibet J; Collins S; Kennedy BP
    Gene; 2000 Dec; 260(1-2):145-53. PubMed ID: 11137300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.